Clinical Trial Update: Syngo NATIVE Contrast Enhanced 3D MRA on 3T Verio Magnet

View source ↗

Summary

Clinical trial update on Syngo NATIVE Contrast Enhanced 3D MRA performed on a 3T Verio MRI system; the Cedars-Sinai Medical Center study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vascular Disease

Snippet

Sponsor: Cedars-Sinai Medical Center | Conditions: Vascular Disease | Status: COMPLETED